Shousun C. Szu - Concepedia

Author

Shousun C. Szu

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Also Known As

S C Szu, S Szu, S. C. SZU, S. C. Szu, S. Szu, S.C. Szu, Shousun C Szu, Shousun C. Szu, Shousun Chen Szu, Shousun Szu

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health Health and Human Development (2HD) Research Network National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Child Health

About

Shousun C. Szu is an author at Eunice Kennedy Shriver National Institute of Child Health and Human Development specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	41	2.2K
2	Natural Sciences	7	7	208
3	Engineering	4	4	200
4	Health Sciences	2	2	93
5	Public Health	1	1	74

Shousun C. Szu

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
The Efficacy of a<i>Salmonella typhi</i>Vi Conjugate Vaccine in Two-to-Five-Year-Old Children Feng Lin, Vô Anh Hó, Ha Ba Khiem, New England Journal of Medicine	2001	470
Safety and Immunogenicity of Vi Conjugate Vaccines for Typhoid Fever in Adults, Teenagers, and 2- to 4-Year-Old Children in Vietnam Zuzana Kossaczká, Feng‐Ying C. Lin, Vô Anh Hó, Infection and Immunity	1999	139
Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals. Shousun C. Szu, Audrey L. Stone, Jonathan Robbins, The Journal of Experimental Medicine Synthetic VirologyImmunologyImmunodominanceImmunotherapyAntibody Engineering	1987	138
Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods Uffe B. Skov Sørensen, Jørgen Henrichsen, Hao-Chia Chen, Microbial Pathogenesis Streptococcus PneumoniaeKlebsiella PneumoniaeGlycobiologyCovalent LinkageCapsular Polysaccharide	1990	136
Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A Ali Fattom, Rachel Schneerson, Shousun C. Szu, Infection and Immunity Pathogenic MicrobiologyMicrobial PathogensImmunologyStaphylococcus AureusMedical Microbiology	1990	132
Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines Shousun C. Szu, David N. Taylor, A C Trofa, Infection and Immunity	1994	120
The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines Vũ Đình Thiểm, Feng‐Ying C. Lin, Do Gia Canh, Clinical and Vaccine Immunology VaccinationVaccine SafetyInfectious Disease PreventionVaccine DevelopmentIgg Anti-vi	2011	119
Relation between structure and immunologic properties of the Vi capsular polysaccharide Shousun C. Szu, X R Li, Audrey L. Stone, Infection and Immunity Whole BacteriaVi Capsular PolysaccharidePathogen DetectionTyphoid FeverPathogenesis	1991	115
Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi Shousun C. Szu, X R Li, Rachel Schneerson, Infection and Immunity Microbial PathogensHumoral ResponseImmunologyImmunodominanceVi Conjugates	1989	101
Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine Douglas C. Watson, John B. Robbins, Shousun C. Szu Infection and Immunity VaccinationVaccine DevelopmentSalmonella InfectionsTyphoid FeverImmunology	1992	100

Page 1